GSK plc (GSK) Financials
GSK Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2026 | 95.7 billion | 71.2 billion |
| June 30, 2026 | 81.3 billion | 58.7 billion |
| March 31, 2026 | 109.4 billion | 79.1 billion |
| Dec. 31, 2025 | 82.0 billion | 60.5 billion |
GSK Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2026 | 3.2 billion | ? |
| June 30, 2026 | 2.9 billion | ? |
| March 31, 2026 | 921.4 million | ? |
| Dec. 31, 2025 | 2.0 billion | ? |
GSK Net Income
| Date | Net Income |
|---|---|
| Sept. 30, 2026 | 2.0 billion |
| June 30, 2026 | 579.3 million |
| March 31, 2026 | 2.4 billion |
| Dec. 31, 2025 | 843.5 million |
GSK Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2026 | 4.0 billion | 29.0 billion | - |
| June 30, 2026 | 4.1 billion | 18.4 billion | - |
| March 31, 2026 | 6.0 billion | 24.4 billion | - |
| Dec. 31, 2025 | 4.6 billion | 19.7 billion | 1.1 billion |
GSK Shares Outstanding
GSK Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2026 | 493.9 million | 2.5 billion | 3.2 billion | - |
| June 30, 2026 | 435.8 million | 4.6 billion | 2.9 billion | - |
| March 31, 2026 | 584.8 million | 2.2 billion | 2.8 billion | - |
| Dec. 31, 2025 | 752.9 million | 3.2 billion | 3.5 billion | - |
GSK Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2026 | 11.7 billion | 3.0 billion |
| June 30, 2026 | 11.1 billion | 3.0 billion |
| March 31, 2026 | 10.1 billion | 2.5 billion |
| Dec. 31, 2025 | 11.6 billion | 3.6 billion |
GSK
Price: $48.26
Dividend Yield: 3.70%
Forward Dividend Yield: 3.78%
Payout Ratio: 52.47%
Dividend Per Share: 1.81 USD
Earnings Per Share: 2.87 USD
P/E Ratio: 17.12
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Volume: 3.7 million
Ebitda: 2.0 billionMarket Capitalization: 98.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 43
DGR3: -1.69%
DGR5: -5.85%
DGR10: -4.42%
DGR20: 0.33%